Page last updated: 2024-11-09

metiamide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Metiamide: A histamine H2 receptor antagonist that is used as an anti-ulcer agent. [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID1548992
CHEMBL ID275446
CHEBI ID6896
SCHEMBL ID534307
SCHEMBL ID11363901
MeSH IDM0013677

Synonyms (72)

Synonym
1-methyl-3-[2-[(5-methyl-1h-imidazol-4-yl)methylsulfanyl]ethyl]thiourea
gtpl1233
3-methyl-1-[2-[(5-methyl-1h-imidazol-4-yl)methylsulfanyl]ethyl]thiourea
sk&f 92058
thiourea, n-methyl-n'-[2-[[(5-methyl-1h-imidazol-4-yl)methyl]thio]ethyl]-
nsc307755
methiamide
1-methyl-3-[2-[[(5-methylimidazol-4-yl)methyl]thio]ethyl]-2-thiourea
nsc-307755
n-methyl-n'-[2-[[(5-methylimidazol-4-yl)methyl]thio]ethyl]thiourea
n-methyl-n'-(2-{[(4-methyl-1h-imidazol-5-yl)methyl]sulfanyl}ethyl)thiourea
AE-641/30115027
metiamide (usan/inn)
D05004
PDSP1_000614
PDSP2_000611
34839-70-8
C07449
metiamide
1-methyl-3-(2-(((5-methylimidazol-4-yl)methyl)thio)ethyl)-2-thiourea
3-methyl-1-(2-((5-methyl-4-imidazolyl)methylthio)ethyl)thiourea
metiamidum [inn-latin]
skf 92058
thiourea, n-methyl-n'-(2-(((5-methyl-1h-imidazol-4-yl)methyl)thio)ethyl)-
sk&f-92058
metiamida [inn-spanish]
nsc 307755
urea, 1-methyl-3-(2-(((5-methylimidazol-4-yl)methyl)thio)ethyl)-2-thio-
L023988
DB08805
CHEMBL275446
chebi:6896 ,
AKOS005065704
bdbm50000382
bdbm81468
cas_34839-70-8
nsc_1548992
3k7670861m ,
metiamidum
metiamida
metiamide [usan:inn:ban]
unii-3k7670861m
HY-15540
CS-1294
1-methyl-3-[2-[[(5-methyl-1h-imidazol-4-yl)methyl]thio]ethyl]thiourea;1-methyl-3-(2-((5-methyl-1h-imidazol-4-yl)methylthio)ethyl)thiourea
metiamide [inn]
metiamide [usan]
SCHEMBL534307
n-methyl-n'-[2-(5-methylimidazol-4-yl)methylthioethyl] thiourea
n-methyl-n'-[2-((5-methyl-4-imidazolyl)-methylthio)ethyl]thiourea
n-methyl-n'-[2-((4-methyl-5-imidazolyl)methylthio)-ethyl]thiourea
n-methyl-n'-[2-((5-methyl-4-imidazolyl)methylthio)ethyl]-thiourea
n-methyl-n'-[2-((5-methyl-4-imidazolyl)methylthio)ethyl]thiourea
n-methyl-n'-[2-((4-methyl-5-imidazolyl)methylthio)ethyl] thiourea
n-methyl-n'-[2-((4-methyl-5-imidazolyl)methylthio)ethyl]-thiourea
n-methyl-n'-[2-(5-methyl-4-imidazolylmethylthio)ethyl]thiourea
n-methyl-n'-[2-((4-methyl-5-imidazolyl)methylthio)ethyl]thiourea
SCHEMBL11363901
n-methyl-n'-(2-([(5-methyl-1h-imidazol-4-yl)methyl]sulfanyl)ethyl)thiourea #
n-methyl-n'-(2-(((5-methylimidazol-4-yl)methyl)thio)ethyl)thiourea
1-methyl-3-(2-(((5-methyl-1h-imidazol-4-yl)methyl)thio)ethyl)thiourea
AC-33693
J-522704
DTXSID80188390
BCP21503
Q6824075
n'-methyl-n-[2-[(5-methyl-1h-imidazol-4-yl)methylsulfanyl]ethyl]carbamimidothioic acid
F84919
MS-23463
1-methyl-3-[2-[[(5-methyl-1h-imidazol-4-yl)methyl]thio]ethyl]thiourea hydrochloride
A847269
AKOS040759156

Research Excerpts

Overview

Metiamide is a safe and highly effective agent in the control of bleeding due to erosive gastritis. Metiamide appeared to be a potent inhibitor of the mesenteric vasodilator response to histamine.

ExcerptReferenceRelevance
"Metiamide seems to be a safe and highly effective agent in the control of bleeding due to erosive gastritis."( Treatment of stress-induced upper gastrointestinal/hemorrhage with metiamide.
Bottomley, MG; MacDonald, AS; Steele, BJ, 1976
)
1.21
"Metiamide appeared to be a potent inhibitor of the mesenteric vasodilator response to histamine at least equal to tripelennamine."( Histamine H1- and H2-receptor vasodilation of canine intestinal circulation.
Jacobson, ED; Miller, TA; Pawlik, W; Tague, LL; Tepperman, BL, 1977
)
0.98

Effects

High doses of pyrilamine increased plasma prolactin levels. Metiamide has a competitive inhibitory effect against impromidine and dimaprit on the isolated perfused lung, kidney and tracheal muscle.

ExcerptReferenceRelevance
"Metiamide has a competitive inhibitory effect against impromidine and dimaprit on the isolated perfused lung, kidney and tracheal muscle."( A comparative study with impromidine (SKF 92676), a potent agonist for histamine H2-receptors.
Aksulu, HE; Ercan, ZS; Türker, RK, 1979
)
0.98
"Metiamide per se has no effect but high doses of pyrilamine increased plasma prolactin levels and augmented the hormone response to histamine."( H1- and H2-histamine receptor antagonists and induced release of prolactin in male rats.
Banzan, AM; Donoso, AO, 1980
)
0.98
"Metiamide has a competitive inhibitory effect against impromidine and dimaprit on the isolated perfused lung, kidney and tracheal muscle."( A comparative study with impromidine (SKF 92676), a potent agonist for histamine H2-receptors.
Aksulu, HE; Ercan, ZS; Türker, RK, 1979
)
0.98

Actions

ExcerptReferenceRelevance
"Metiamide did not produce these effects except for the relaxation of the sustained contraction."( Unusual effects of histamine antagonists on canine nasal blood vessels.
Ichimura, K; Jackson, RT,
)
0.85

Treatment

Pretreatment with metiamide (2 mg i.c.v.) did not significantly antagonise either the hypotension or bradycardia induced by clonidine (25 mug) Treatment of metiamides or alpha-fluoro-methyl-histidine did not affect the pattern of LH secretion.

ExcerptReferenceRelevance
"In metiamide-treated tissues, 20 mM SAN caused an immediate fall in potential difference and an increase in resistance; 2 mM SAN and 20 mM ASA produced similar qualitative electrical changes, but only those induced by ASA were reversible."( Effect of simulated systemic administration of aspirin, salicylate, and indomethacin on amphibian gastric mucosa.
Kasdon, E; Marrone, G; Rowe, PH; Silen, W; Starlinger, MJ, 1986
)
0.78
"Pretreatment with metiamide, an H2 receptor blocker, and methysergide, a 5-HT antagonist, did not significantly alter the cataleptic effect of morphine."( Involvement of histaminergic mechanisms in the cataleptogenic effect of morphine in mice.
Balsara, JJ; Chandorkar, AG; Jadhav, JH; Muley, MP, 1982
)
0.59
"Pretreatment with metiamide (2 mg i.c.v.) did not significantly antagonise either the hypotension or bradycardia induced by clonidine (25 mug), but induced marked behavioural changes."( No evidence for central histamine-receptor involvement with the hypotensive effect of clonidine in cats.
Finch, L; Hicks, PE, 1976
)
0.58
"Treatment of metiamide or alpha-fluoro-methyl-histidine did not affect the pattern of LH secretion."( The participation of histaminergic receptors of the rostral hypothalamus on the tonic release of luteinizing hormone (LH) in adult spayed rats under estrogen and progesterone treatment.
Alvarez, EO; Horno, NM, 1991
)
0.63

Toxicity

ExcerptReferenceRelevance
" At toxic concentrations, two of the least potent analogs, SK&F 92909 and SK&F 9205A both caused a rapid decrease in hepatocyte O2 consumption and ATP content which occurred before any evidence of cell injury."( Toxicity of H2-receptor antagonists to isolated rat hepatocytes: structure-activity relationships.
Alberts, D; Brown, TH; Durant, GJ; Lupo, S; Rush, GF; Yodis, LA, 1988
)
0.27

Pharmacokinetics

ExcerptReferenceRelevance
" The data give pharmacodynamic basis for the interaction of histamine-H2-receptor antagonists with bone marrow cells."( Pharmacodynamic basis for the interaction of cimetidine with the bone marrow stem cells (CFUS).
Byron, JW, 1980
)
0.26

Dosage Studied

The effect of a specific histamine H2-receptor antagonist, metiamide, on the acid dose-response curves for pentagastrin or methacholine was studied in rats provided with Heidenhain pouches. Metiamide suppressed the development of stress ulcers, most markedly in doses of 0.100 microng/min.

ExcerptRelevanceReference
" A linear dose-response relationship was obtained for theophylline."( Acid secretion by guinea-pig isolated stomach.
Holton, P; Spencer, J, 1976
)
0.26
" Metamide, at doses of 3 X 10(-6)M, and 3 X 10(-5)M, caused a parallel displacement of the histamine dose-response curve, indicating competitive antagonism."( A quantitative study of metiamide, a histamine H2-antagonist, on the isolated whole rat stomach.
Bunce, KT; Parsons, ME, 1976
)
0.56
"Cumulative dose-response curves for histamine were determined on acid secretion from the isolated guinea pig gastric mucosa."( Analysis of the actions of cimetidine and metiamide on gastric acid secretion in the isolated guinea pig gastric mucosa.
Olbe, L; Ryberg, B; Sjöstrand, SE, 1977
)
0.52
" On Cimetidine administered at a usual dosage over a 4--6 week period, serious side-effects must not be expected."( [Treatment of peptic ulcer with histamine H2 receptor antagonists].
Demling, L; Domschke, S; Domschke, W, 1977
)
0.26
" When the H2-receptor antagonists burimamide, metiamide and cimetidine were labelled with 35S, 14C or 3H and dosed to rats, whole body autoradiography showed that the stomach was predominantly labelled in the glandular mucosa from 5 to 120 min after administration."( Localization of histamine and histamine H2-receptor antagonists in the gastric mucosa.
Cross, SA, 1977
)
0.52
" Isoprenaline evoked vasodilation and propranolol (beta-adrenoceptor antagonist) caused a parallel shift to the right of the isoprenaline log dose-response curve."( Identification of beta-adrenoceptors and histamine receptors in the cat nasal vasculature.
Hiley, CR; Wilson, H; Yates, MS,
)
0.13
" In addition, dose-response curves obtained on the mesenteric artery demonstrated that the H2-receptor mediated depressor responses coincided with cyclic AMP increases."( Relationship between histamine-induced changes of cyclic AMP and mechanical activity on smooth muscle preparations of the guinea-pig ileum and the rabbit mesenteric artery.
Butzheinen, R; Reinhardt, D; Ritter, E; Schümann, HJ, 1979
)
0.26
" The effect of a specific histamine H2-receptor antagonist, metiamide, on the acid dose-response curves for pentagastrin or methacholine was studied in rats provided with Heidenhain pouches."( Displacement by metiamide of the dose-response curves to pentagastrin and methacholine in the conscious rat.
Lundell, L, 1975
)
0.84
"Postnatal development of histamine receptors in the canine pulmonary circulation was examined utilizing histamine cumulative dose-response curves of pulmonary arteries isolated from neonatal and adult dogs."( Postnatal changes in response of canine neonatal pulmonary arteries to histamine.
Arroyave, CM; Grover, RF; Newman, JH; Reeves, JT; Souhrada, JF, 1979
)
0.26
", pretreatment for 1 hour) produced a dose dependent shift of the histamine wheal dose-response curve to the right in a parallel fashion."( Cutaneous vascular histamine H1 and H2 receptors in the guinea-pig: the histamine skin wheal as a cutaneous vascular model.
Cheng, HC; Munro, NL; Reavis, OK; Woodward, JK, 1979
)
0.26
" 2 The effect of histamine on both mitogen and antigen dose-response curves suggests a non-competitive, probably physiological antagonism."( Inhibition of guinea-pig lymphocyte activation by histamine and histamine analogues.
Beets, JL; Dale, MM, 1979
)
0.26
" This dose-response curve could be shifted to the right by administration of dimethylaminoethyl-N-p-methoxybenzyl-N-alpha-aminopyridine (mepyramine; H1-antagonist)."( [Involvement of both H1- and H2-receptors in the depressor responses of blood pressure to histamine in the rat (author's transl)].
Szelenyi, I; Thiemer, K, 1977
)
0.26
" The normalized dose-response relations for histamine with an IMX background and for carbamylcholine were also similar in these two fractions."( The actions of secretagogues on oxygen uptake by isolated mammalian parietal cells.
Soll, AH, 1978
)
0.26
" Mepyramine, an H1 receptor antagonist (H1A), inhibited this effect, displacing the histamine dose-response curve to the right."( Histamine receptors in mesenteric circulation of the cat and rat.
Guth, PH; Smith, E, 1978
)
0.26
"3 Bradykinin, 5-hydroxytryptamine (5-HT) and histamine were injected intra-arterially and intra-portally and dose-response curves constructed from these data."( A comparison of the effects of bradykinin, 5-hydroxytryptamine and histamine on the hepatic arterial and portal venous vascular beds of the dog: histamine H1 and H2-receptor populations.
Richardson, PD; Withrington, PG, 1977
)
0.26
") shifted the dose-response curve of clonidine (i."( Site and mode of action of clonidine in the central nervous system.
Karppanen, H; Paakkari, I; Paakkari, P, 1976
)
0.26
"The clinical, endoscopic, and biochemical effects of metiamide, a histamine H2-receptor antagonist, in therapeutic dosage have been studied in a 28-day open trial in patients with duodenal ulcer disease."( Early clinical experience with metiamide, a histamine H2-receptor antagonist, in patients with duodenal ulcer.
Dale, G; Reed, JD; Thompson, MH; Venables, CW, 1975
)
0.79
"0 mg/kg dosage group, however, demonstrated significantly fewer ulcers than the saline animals and the lesions that did occur were significantly smaller than those noted in the control animals."( The effects of metiamide on the "activity-stress" ulcer in rats.
Cash, RJ; Houser, VP; van Hart, DA, 1975
)
0.61
"5 X 10(-6) mol/kg), causes displacement of the histamine dose-response curve."( Histamine receptors in peripheral vascular beds in the cat.
Flynn, SB; Owen, DA, 1975
)
0.25
" The experiments with burimamide did not permit the calculation of dose-response relationship."( The inhibition of salivary secretion by histamine H2-antagonists--a study on the cat submandibular gland.
Erjavec, F; Stanovnik, L, 1983
)
0.27
" The H1-antagonist chlorpheniramine shifted to the right the dose-response curves to histamine and to 2-aminoethylthiazole with the kinetics of the competitive antagonism."( Histamine receptors in the human ureter.
Bertaccini, G; Bezzi, E; Potenzoni, D; Zappia, L, 1983
)
0.27
" Following control measurements of Pm and arteriolar and venular dimensions, dose-response curves of arteriolar and venular dimensions to topical norepinephrine (10(-10) M to 10(-3) M) was obtained."( Microvascular responses to E. coli endotoxin with altered adrenergic activity.
Baker, CH; Wilmoth, FR, 1984
)
0.27
" If the mice were dosed daily (i."( Effect of histamine agonists and antagonists on the production of murine reaginic antibodies.
Baker, AP; Chakrin, LW; Holden, DA; Smith, WJ; Sung, CP, 1981
)
0.26
"The present work investigates (a) the modification by pretreatment with selective H1- and H2-receptor antagonists on the dose-response curves (DRC) to histamine for heart rate, blood pressure, renal arterial blood flow and renal vascular resistance in anesthetized dogs, and (b) the characteristics of the DRC to histamine in canine isolated renal artery."( Histamine H1- and H2-receptors in canine renal artery in vivo and in vitro.
Bedate, H; Esplugues, J; Moragues, A; Morcillo, E, 1981
)
0.26
" SK & F 91581 (10(-4) M) had no effect upon these responses and amodiaquine (10(-5) M) depressed the maxima of the rate response dose-response curves."( Uptake and metabolism of histamine in guinea-pig isolated atria and their relationship to the pharmacological responses.
Broadley, KJ; Owen, DA; Smith, IR; Wilson, C, 1980
)
0.26
" A limit to the shift of cumulative dose-response curves for the inotropic response suggested an H1 receptor resistant component."( A positive inotropic response of guinea pig isolated atria to histamine not mediated via H1 or H2 receptors.
Broadley, KJ; Wilson, C, 1980
)
0.26
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
imidazolesA five-membered organic heterocycle containing two nitrogen atoms at positions 1 and 3, or any of its derivatives; compounds containing an imidazole skeleton.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (1)

PathwayProteinsCompounds
Metiamide Action Pathway1012

Bioassays (29)

Assay IDTitleYearJournalArticle
AID1135357Antagonist at histamine H2 receptor in guinea pig atrium assessed as inhibition of histamine-induced response1977Journal of medicinal chemistry, Jul, Volume: 20, Issue:7
Cyanoguanidine-thiourea equivalence in the development of the histamine H2-receptor antagonist, cimetidine.
AID1123890Inhibition of gastrin tetrapeptide-induced gastric secretion in beagle dog assessed as total acid output at 16 mg/kg administered directly into stomach via gastric cannula measured after 2 hrs of stimulation1979Journal of medicinal chemistry, Mar, Volume: 22, Issue:3
2-Mercaptoacetamidines as gastric antisecretory agents.
AID1123901Inhibition of gastrin tetrapeptide-induced gastric secretion in beagle dog assessed as titratable acid at 32 mg/kg administered directly into stomach via gastric cannula measured after 2 hrs of stimulation1979Journal of medicinal chemistry, Mar, Volume: 22, Issue:3
2-Mercaptoacetamidines as gastric antisecretory agents.
AID87703Histamine H2 receptor blocking activity was determined in the isolated guinea pig right atrium against histamine stimulated tachycardia1986Journal of medicinal chemistry, Jan, Volume: 29, Issue:1
Dipole moment in relation to H2 receptor histamine antagonist activity for cimetidine analogues.
AID1123888Inhibition of gastrin tetrapeptide-induced gastric secretion in beagle dog assessed as volume at 16 mg/kg administered directly into stomach via gastric cannula measured after 2 hrs of stimulation1979Journal of medicinal chemistry, Mar, Volume: 22, Issue:3
2-Mercaptoacetamidines as gastric antisecretory agents.
AID1135360Ionization constant, pKa of the imidazole ring of the compound1977Journal of medicinal chemistry, Jul, Volume: 20, Issue:7
Cyanoguanidine-thiourea equivalence in the development of the histamine H2-receptor antagonist, cimetidine.
AID1133971Antagonist activity at histamine receptor (unknown origin) assessed as shift in histamine-induced response at 5 x 10 '-5 M relative to control1977Journal of medicinal chemistry, Apr, Volume: 20, Issue:4
Experimental antiulcer drugs. 1. Indole-1-alkanamides and pyrrole-1-alkanamides.
AID1123902Inhibition of gastrin tetrapeptide-induced gastric secretion in beagle dog assessed as total acid output at 32 mg/kg administered directly into stomach via gastric cannula measured after 2 hrs of stimulation1979Journal of medicinal chemistry, Mar, Volume: 22, Issue:3
2-Mercaptoacetamidines as gastric antisecretory agents.
AID89556Evaluated for antagonist activity against histamine H3 receptor and represented as KB.1990Journal of medicinal chemistry, Jan, Volume: 33, Issue:1
Histamine H3 ligands: just pharmacological tools or potential therapeutic agents?
AID1123889Inhibition of gastrin tetrapeptide-induced gastric secretion in beagle dog assessed as titratable acid at 16 mg/kg administered directly into stomach via gastric cannula measured after 2 hrs of stimulation1979Journal of medicinal chemistry, Mar, Volume: 22, Issue:3
2-Mercaptoacetamidines as gastric antisecretory agents.
AID192854Determined as volume/100 g and at 75 mg/kg peroral dose1980Journal of medicinal chemistry, Mar, Volume: 23, Issue:3
Inhibition of histamine-induced gastric secretion by flavone-6-carboxylic acids.
AID1123900Inhibition of gastrin tetrapeptide-induced gastric secretion in beagle dog assessed as volume at 32 mg/kg administered directly into stomach via gastric cannula measured after 2 hrs of stimulation1979Journal of medicinal chemistry, Mar, Volume: 22, Issue:3
2-Mercaptoacetamidines as gastric antisecretory agents.
AID191884Gastric juice volume when tested orally in rat ligated stomach preparation at 150 mg/kg peroral dose1980Journal of medicinal chemistry, Mar, Volume: 23, Issue:3
Inhibition of histamine-induced gastric secretion by flavone-6-carboxylic acids.
AID1135362Octanol-water partition coefficient, log P of the compound at pH 9.21977Journal of medicinal chemistry, Jul, Volume: 20, Issue:7
Cyanoguanidine-thiourea equivalence in the development of the histamine H2-receptor antagonist, cimetidine.
AID1123907Antagonist activity at histamine H2 receptor in Charles River rat assessed as inhibition of histamine-mediated electrically stimulated uterine contraction1979Journal of medicinal chemistry, Mar, Volume: 22, Issue:3
Inhibition of gastric acid secretion by 1,8-naphthyridin-2(1H)-ones.
AID1123909Antagonist activity at histamine H2 receptor in Hartley guinea pig atrium assessed as ratio of histamine concentration required in control to that required in presence of compound to increase atrium rate by 50 beats/min at 10 ug/mL1979Journal of medicinal chemistry, Mar, Volume: 22, Issue:3
Inhibition of gastric acid secretion by 1,8-naphthyridin-2(1H)-ones.
AID28912Partition coefficient (logD) (octanol/borax buffer)1986Journal of medicinal chemistry, Jan, Volume: 29, Issue:1
Dipole moment in relation to H2 receptor histamine antagonist activity for cimetidine analogues.
AID182338% inhibition in total acid secretion when tested orally in rat ligated stomach preparation at 75 mg/kg peroral dose1980Journal of medicinal chemistry, Mar, Volume: 23, Issue:3
Inhibition of histamine-induced gastric secretion by flavone-6-carboxylic acids.
AID191887Gastric juice volume when tested orally in rat ligated stomach preparation at 75 mg/kg peroral dose1980Journal of medicinal chemistry, Mar, Volume: 23, Issue:3
Inhibition of histamine-induced gastric secretion by flavone-6-carboxylic acids.
AID88018Evaluated for antagonist activity against histamine H2 receptor and represented as KB.1990Journal of medicinal chemistry, Jan, Volume: 33, Issue:1
Histamine H3 ligands: just pharmacological tools or potential therapeutic agents?
AID86605Evaluated for antagonist activity against histamine H1 receptor and represented as KB.1990Journal of medicinal chemistry, Jan, Volume: 33, Issue:1
Histamine H3 ligands: just pharmacological tools or potential therapeutic agents?
AID1123913Antisecretory activity in Beagle dog assessed as inhibition of histamine-stimulated gastric acid secretion at 20 mg/kg, po administered 1 hr prior to histamine challenge measured every 30 mins for 90 mins relative to placebo control1979Journal of medicinal chemistry, Mar, Volume: 22, Issue:3
Inhibition of gastric acid secretion by 1,8-naphthyridin-2(1H)-ones.
AID192851Determined as volume/100 g and at 150 mg/kg peroral dose1980Journal of medicinal chemistry, Mar, Volume: 23, Issue:3
Inhibition of histamine-induced gastric secretion by flavone-6-carboxylic acids.
AID182336% inhibition in total acid secretion when tested orally in rat ligated stomach preparation at 150 mg/kg peroral dose1980Journal of medicinal chemistry, Mar, Volume: 23, Issue:3
Inhibition of histamine-induced gastric secretion by flavone-6-carboxylic acids.
AID1123910Antisecretory activity in Beagle dog assessed as inhibition of gastrin tetrapeptide-stimulated gastric acid secretion at 20 mg/kg, po administered 1 hr prior to gastrin tetrapeptide challenge measured every 30 mins for 90 mins relative to placebo control1979Journal of medicinal chemistry, Mar, Volume: 22, Issue:3
Inhibition of gastric acid secretion by 1,8-naphthyridin-2(1H)-ones.
AID1133970Antagonist activity at histamine receptor (unknown origin) assessed as shift in histamine-induced response at 10 '-5 M relative to control1977Journal of medicinal chemistry, Apr, Volume: 20, Issue:4
Experimental antiulcer drugs. 1. Indole-1-alkanamides and pyrrole-1-alkanamides.
AID1135358Antagonist at histamine H2 receptor in rat uterus assessed as inhibition of histamine-induced response1977Journal of medicinal chemistry, Jul, Volume: 20, Issue:7
Cyanoguanidine-thiourea equivalence in the development of the histamine H2-receptor antagonist, cimetidine.
AID1135363Solubility of the compound in water at 37 degC1977Journal of medicinal chemistry, Jul, Volume: 20, Issue:7
Cyanoguanidine-thiourea equivalence in the development of the histamine H2-receptor antagonist, cimetidine.
AID1346133Rat H2 receptor (Histamine receptors)1997British journal of pharmacology, Nov, Volume: 122, Issue:5
Heterologous expression of rat epitope-tagged histamine H2 receptors in insect Sf9 cells.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (594)

TimeframeStudies, This Drug (%)All Drugs %
pre-1990571 (96.13)18.7374
1990's19 (3.20)18.2507
2000's3 (0.51)29.6817
2010's1 (0.17)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 25.80

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index25.80 (24.57)
Research Supply Index6.48 (2.92)
Research Growth Index3.92 (4.65)
Search Engine Demand Index36.71 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (25.80)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials25 (4.01%)5.53%
Reviews17 (2.72%)6.00%
Case Studies20 (3.21%)4.05%
Observational0 (0.00%)0.25%
Other562 (90.06%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]